<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02768129</url>
  </required_header>
  <id_info>
    <org_study_id>1411-003</org_study_id>
    <nct_id>NCT02768129</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation for Chronic Low Back Pain</brief_title>
  <official_title>tDCS for Chronic Low Back Pain: A Study Examining the Effect of Transcranial Direct Current Stimulation on the Emotional Response to Chronic Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Butler Hospital</source>
  <brief_summary>
    <textblock>
      The goal of this study is to investigate the role of central neural pathways in mediating
      chronic pain. The aim of the study is to test the effect of stimulating brain regions that
      are part of a network underlying central pain processing using a non-invasive brain
      stimulation technique, transcranial Direct Current Stimulation (tDCS). Prior studies have
      used tDCS to target both sensory related cortical areas and those important for higher-order
      representations of pain. This study will target brain regions important for the behavioral
      response to the chronic sensation of pain. The hypothesis is that stimulation of these brain
      regions can modulate not only the affective component of pain, but ultimately also improve
      functioning and quality of life. This hypothesis will be tested by treating study
      participants eighteen and older with chronic low back pain (CLBP) of greater than six months
      using tDCS. To be part of this study, participants must meet all the inclusion and exclusion
      criteria.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">April 4, 2018</completion_date>
  <primary_completion_date type="Actual">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>West Haven-Yale Multidimensional Pain Inventory (General Activity Subscale) Rating</measure>
    <time_frame>8 weeks total</time_frame>
    <description>Subscale C of the West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) is a validated measure of chronic pain's effects on functioning. Ranging from 0-108, higher scores indicate more activity (better outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Anxiety Symptom Scale Rating</measure>
    <time_frame>8 weeks total</time_frame>
    <description>The Pain Anxiety Symptom Scale (PASS-20) is a validated measure of pain-related avoidance and fear. Total score ranges 0-100. Higher scores indicate greater pain anxiety.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>10 sessions sham transcranial direct current stimulation (tDCS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>active tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 sessions active transcranial direct current stimulation (tDCS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation</intervention_name>
    <description>active stimulation: 2 milliamp (mA), 20 mins</description>
    <arm_group_label>active tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham transcranial direct current stimulation</intervention_name>
    <description>sham stimulation</description>
    <arm_group_label>sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Low Back Pain â‰¥ 6 months duration in the lumbar region, present more than half
             the days of the month, and on average be at a moderate level of severity in the last
             month

          -  At least one trial of physician recommended medication (e.g. acetaminophen, NSAIDS,
             skeletal muscle relaxants)

          -  Pre-existing opioid and non-opioid pain medication must be non-existent or stable
             (medications have not changed for one month)

          -  Be able to understand, read and write English

          -  If female and of childbearing age, agree to use acceptable birth control during the
             study treatment period (oral contraceptives, history of tubal ligation, history of a
             hysterectomy, or a reliable barrier method)

        Exclusion Criteria:

          -  Lifetime Diagnostic and Statistical Manual (DSM) IV diagnosis of bipolar disorder,
             schizophrenia, or other chronic psychotic condition

          -  Current DSM-IV diagnosis of substance dependence for alcohol, sedative/hypnotic drugs,
             stimulants, cocaine

          -  Current cancer, infection, or inflammatory arthritis

          -  Broken skin or other lesions in the area of the electrodes

          -  Uncontrolled medical problems, such as diabetes mellitus, hypertension, pulmonary or
             airway disease, heart failure, coronary artery disease, or any other condition that
             poses a risk for the subject during participation

          -  Presence of metal in the cranial cavity

          -  Holes in the skull made by trauma or surgery

          -  Pacemakers, medication pumps, and other implanted electronic hardware

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 9, 2016</study_first_submitted>
  <study_first_submitted_qc>May 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2016</study_first_posted>
  <results_first_submitted>July 11, 2019</results_first_submitted>
  <results_first_submitted_qc>July 29, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 20, 2019</results_first_posted>
  <last_update_submitted>July 29, 2019</last_update_submitted>
  <last_update_submitted_qc>July 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 3, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/29/NCT02768129/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of the 30 participants that were consented, 9 participants were ineligible, withdrew, or were lost to contact before commencing tDCS.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sham tDCS</title>
          <description>10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: sham</description>
        </group>
        <group group_id="P2">
          <title>Active tDCS</title>
          <description>10 sessions active transcranial direct current stimulation (tDCS)
transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The data collected from the 21 participants who completed tDCS treatment (either active or sham) is included in the analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>Active tDCS</title>
          <description>10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: active : 2 mA, 20 mins</description>
        </group>
        <group group_id="B2">
          <title>Sham tDCS</title>
          <description>10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: sham</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.7" spread="8.8"/>
                    <measurement group_id="B2" value="60.7" spread="11.8"/>
                    <measurement group_id="B3" value="63.1" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Years of Education</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.0" spread="2.6"/>
                    <measurement group_id="B2" value="14.7" spread="2.6"/>
                    <measurement group_id="B3" value="14.4" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>West Haven-Yale Multidimensional Pain Inventory (General Activity Subscale) Rating</title>
        <description>Subscale C of the West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) is a validated measure of chronic pain's effects on functioning. Ranging from 0-108, higher scores indicate more activity (better outcome).</description>
        <time_frame>8 weeks total</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham tDCS</title>
            <description>10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: sham</description>
          </group>
          <group group_id="O2">
            <title>Active tDCS</title>
            <description>10 sessions active transcranial direct current stimulation (tDCS)
transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins</description>
          </group>
        </group_list>
        <measure>
          <title>West Haven-Yale Multidimensional Pain Inventory (General Activity Subscale) Rating</title>
          <description>Subscale C of the West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) is a validated measure of chronic pain's effects on functioning. Ranging from 0-108, higher scores indicate more activity (better outcome).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.3" spread="17.7"/>
                    <measurement group_id="O2" value="48.4" spread="21.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Anxiety Symptom Scale Rating</title>
        <description>The Pain Anxiety Symptom Scale (PASS-20) is a validated measure of pain-related avoidance and fear. Total score ranges 0-100. Higher scores indicate greater pain anxiety.</description>
        <time_frame>8 weeks total</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham tDCS</title>
            <description>10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: sham</description>
          </group>
          <group group_id="O2">
            <title>Active tDCS</title>
            <description>10 sessions active transcranial direct current stimulation (tDCS)
transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Anxiety Symptom Scale Rating</title>
          <description>The Pain Anxiety Symptom Scale (PASS-20) is a validated measure of pain-related avoidance and fear. Total score ranges 0-100. Higher scores indicate greater pain anxiety.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.4" spread="22.0"/>
                    <measurement group_id="O2" value="26.3" spread="23.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sham tDCS</title>
          <description>10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: sham</description>
        </group>
        <group group_id="E2">
          <title>Active tDCS</title>
          <description>10 sessions active transcranial direct current stimulation (tDCS)
transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>small sample (N=21), participants not stratified by premorbid anxiety levels, inability to guarantee optimal targeting of left dorsal anterior cingulate cortex (dACC) in all participants, inability to address laterality effects of pain perception</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Benjamin Greenberg</name_or_title>
      <organization>Butler Hospital</organization>
      <phone>(401) 455-6200</phone>
      <email>bgreenberg@butler.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

